Are you ready to enhance your understanding and expertise in the evolving field of chimeric antigen receptor (CAR) T-cell therapy for chronic lymphocytic leukemia (CLL)? Join us for an interactive exploration of the latest clinical evidence and strategies aimed at effectively positioning CAR T-cell therapy in CLL care. Throughout this activity, you will embark on a personalized educational journey tailored to your knowledge and learning needs. As you engage with the material, you will receive real-time feedback and resources aligned with your level of knowledge and comprehension. Prepare to deepen your expertise and transform your approach to CLL management with this dynamic learning experience, designed to bolster CAR T-cell knowledge and support you in empowering your patients to actively participate in their CLL care.
- Provider:PRIME Education, Inc. (PRIME®)
- Activity Link: https://primeinc.org/online/positioning-car-t-cell-therapy-cll-treatment-landscape-leveraging-artificial
- Start Date: 2024-03-28 05:00:00
- End Date: 2024-03-28 05:00:00
- Credit Details: IPCE Credits: 1.0 hours
AAPA Category 1 Credit™️: 1.0 hours
AMA PRA Category 1 Credit™️: 1.0 hours
Nursing: 1.0 hours
Pharmacy: 1.0 hours - Commercial Support: Source: Bristol-Myers Squibb Company - Amount: 49666.67 - Is Kind Support: False
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: No, it's free
- Measured Outcome: Learner Knowledge, Learner/Team Competence, Learner/Team Performance
- Provider Ship: Directly Provided
- Registration: Open to all